Nola Hylton, PhD and Duan Xu, PhD Inducted into Medical and Biological Engineering Elite

Nola Hylton, PhD and Duan Xu, PhD have been inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows, Class of 2021. This is among one of the highest professional distinctions given to medical and biological engineers.

Dr. Hylton is a professor in Residence in the UC San Francisco Department of Radiology and Biomedical Imaging, and director of the Breast Imaging Research Group. She has been integrally involved in the development of magnetic resonance imaging (MRI) for the detection, diagnosis and staging of breast cancer. She was nominated, reviewed and elected by peers and members of the College of Fellows based on the following:

“Development of quantitative MRI/PET techniques for breast cancer diagnosis and therapy assessment, impacting the health of women globally.”

Dr. Xu is a professor in residence at UCSF Radiology and leads the Imaging Research for Neurodevelopment Laboratory UCSF Parnassus and Mission Bay. His research focuses on investigating new MRI techniques using primary applications in pediatric neuroradiology. He was nominated, reviewed and elected by peers and members of the College of Fellows based on the following:

“Outstanding contributions and leadership in the development of innovative pediatric MR imaging techniques advancing healthcare for children.”

The College of Fellows is made up of the top two percent of medical and biological engineers. According to the AIMBE, “the most accomplished and distinguished engineering and medical school chairs, research directors, professors, innovators, and successful entrepreneurs comprise the College of Fellows. AIMBE Fellows are regularly recognized for their contributions in teaching, research, and innovation.” 

Drs. Hylton and Xu will be a part of a formal induction ceremony will be held during AIMBE’s 2021 Annual Event on March 26. They will be inducted with 174 colleagues who make up the AIMBE Fellow Class of 2021.

Related Content